Author Details

Sehn, L., University of British Columbia BC Cancer Agency, Canada

  • Vol 22, No 4 (2015) - Clinical Trials
    An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT
    Abstract  PDF  HTML